Removing the Risk in Risk-Based Monitoring – What we have Learnt in the Last Four 
Years from the Practical Implementation of RBM.

Recorded on September 12, 2016

Hosted by Francois Torche, CEO, CluePoints and Craig Serra, Senior Director, Data Management BPO, Clinical Services and Operations, Pfizer. 

This webinar recording details best practices for onboarding RBM that have been gained through implementation involving smaller and larger BioPharma sponsors and CROs.

The presenters will showcase the benefits derived from an integrated solution featuring upfront Risk Assessment, Overall Data Quality Oversight, Key Risk Indicators (KRIs) and the process to drive Targeted Monitoring and Source Data Verification (SDV). They will describe the process, people and technology elements that make for the successful planning and execution of RBM, revealing how best to enable your organization to embark on your RBM journey – taking what on the surface appears complicated and making it much more straight forward.

  • Highlight best practices for RBM study planning and execution and key pitfalls to avoid
  • Draw a clear line of sight between study risk assessment, operational KRIs, and quality oversight methods
  • Capitalize on the best use of data analytics in central data review
  • Determine how to integrate RBM technology within the new operational process




Copyright © 2015 CluePoints®. All rights reserved.



Fix the following errors: